An open-label study on the pharmacokinetics (PK) of pitavastatin (NK-104) when administered concomitantly with fenofibrate or gemfibrozil in healthy volunteers.

被引：27
|
作者：
Mathew, P
Cuddy, T
Tracewell, WG
Salazar, D
机构：
[1] MDS Pharma Serv, Neptune, NJ USA
[2] Sankyo Pharma Dev, La Jolla, CA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2004年 / 75卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2003.11.125
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P33 / P33
页数：1
相关论文
共 50 条
  • [1] An open label study to investigate the pharmacokinetics (PK) of ebastine in patients with liver impairment compared with healthy volunteers.
    Vargas, R
    Semiond, D
    Sanderink, G
    Noveck, R
    McMahon, FG
    Lasseter, K
    Gillen, M
    Davidson, J
    DePhillips, S
    Rao, Z
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 97 - 97
  • [2] An Open-Label Study to Assess the Effect of Itraconazole and Rifampin on Parsaclisib Pharmacokinetics When Administered Orally in Healthy Participants
    Li, Jia
    Rockich, Kevin
    Yuska, Brad
    Zhou, Gongfu
    Epstein, Noam
    Punwani, Naresh
    Chen, Xuejun
    Yeleswaram, Swamy
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 60 (11): : 1519 - 1526
  • [3] Open-label, nonrandomized study of the effects of gatifloxacin on the pharmacokinetics of midazolam in healthy male volunteers
    Grasela, DM
    LaCreta, FP
    Kollia, GD
    Randall, DM
    Uderman, HD
    [J]. PHARMACOTHERAPY, 2000, 20 (03): : 330 - 335
  • [4] Effect of fluconazole on the pharmacokinetics of fuzuloparib: an open-label, crossover study in Chinese healthy male volunteers
    Xue Chen
    Feng Yang
    Jiao Zhao
    Qi Tang
    Jianfu Heng
    Jun Deng
    Jin Zhang
    Yong Chen
    Kunyan Li
    Jing Wang
    [J]. Cancer Chemotherapy and Pharmacology, 2022, 89 : 141 - 148
  • [5] Effect of fluconazole on the pharmacokinetics of fuzuloparib: an open-label, crossover study in Chinese healthy male volunteers
    Chen, Xue
    Yang, Feng
    Zhao, Jiao
    Tang, Qi
    Heng, Jianfu
    Deng, Jun
    Zhang, Jin
    Chen, Yong
    Li, Kunyan
    Wang, Jing
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 89 (01) : 141 - 148
  • [6] AN OPEN-LABEL STUDY TO ASSESS THE EFFECT OF ITRACONAZOLE AND RIFAMPIN ON INCB000928 PHARMACOKINETICS WHEN ADMINISTERED ORALLY IN HEALTHY PARTICIPANTS
    Yang, Y.
    Gong, X.
    Wang, P.
    Liu, X.
    Getsy, J.
    Yeleswaram, S.
    Chen, X.
    Rockich, K.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S26 - S26
  • [7] An open-label, crossover study of the pharmacokinetics of insoluble Drug Delivery®-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers
    Penn, R
    Williams, RX
    Guha-Ray, DK
    Sawyers, WG
    Braun, SL
    Rains, KT
    [J]. CLINICAL THERAPEUTICS, 2006, 28 (01) : 45 - 54
  • [8] The Effects of Boceprevir and Telaprevir on the Pharmacokinetics of Maraviroc: An Open-Label, Fixed-Sequence Study in Healthy Volunteers
    Vourvahis, Manoli
    Plotka, Anna
    Kantaridis, Constantino
    Fang, Annie
    Heera, Jayvant
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 65 (05) : 564 - 570
  • [9] Pharmacokinetics, pharmacodynamics, and tolerability of BCD-017, a novel pegylated filgrastim: Results of open-label controlled phase I study with dose escalation in healthy volunteers.
    Nikitin, Kirill D.
    Fitilev, Sergei B.
    Chernovskaya, Tatiana V.
    Rudenko, Elena G.
    Vozzhaev, Alexander V.
    Titarova, Yulia Y.
    Yakushev, Vadim A.
    Ivanov, Roman A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [10] A phase I, open-label study of the safety and pharmacokinetics (PK) of pazopanib (P) and lapatinib (L) administered concurrently.
    Dejonge, M.
    Savage, S.
    Verweij, J.
    Collins, T. S.
    Eskens, F.
    Whitehead, B.
    Suttle, A. B.
    Pandite, L. B.
    Ho, P. T.
    Hurwitz, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 142S - 142S
12345